

Pulmonary
Request Sample Report
The Pulmonary Heart Valve Replacement market is experiencing significant growth due to increasing incidences of congenital heart defects and advancements in valve technologies. The global market size is projected to reach approximately $1 billion by 2030, driven by rising demand for minimally invasive procedures and improved healthcare infrastructure. Request Sample Report
◍ Edwards Lifesciences
◍ Boston Scientific
◍ Medtronic
◍ St. Jude Medical
◍ Abbott
◍ Cryolife
The pulmonary heart valve replacement market features key players like Edwards Lifesciences, Boston Scientific, Medtronic, St. Jude Medical, Abbott, and Cryolife. These companies drive market growth through innovative products, strategic collaborations, and clinical advancements. Sales revenues include:
- Edwards Lifesciences: ~$5 billion
- Abbott: ~$43 billion
- Medtronic: ~$30 billion Request Sample Report
Hospitals
Emergency Centre ◍ Ambulatory Surgery Centre
Open Heart Surgery
Minimally Invasive Surgery
Request Sample Report
Request Sample Report
$ 1.71 Billion